Transdermal Drug Patches: The Next Generation

Aug 04, 2011, 05:04 ET from Reportlinker

NEW YORK, Aug. 4, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Transdermal Drug Patches: the Next Generation

http://www.reportlinker.com/p0581169/Transdermal-Drug-Patches-the-Next-Generation.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. New patch designs and formulation technologies are expanding the type and number of prescription therapies and treatments that can be effectively administered to patients and consumers. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for prescription drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings.

Highlights

• Analyzes and evaluates the new generation of transdermal drug patch products and assesses risks and market potential

• Analyzes patch designs, technologies and patch development issues

• Provides assessments of new generation drug patch products in eight key product categories

• Provides market data and forecasts to 2015

• Profiles patch manufacturers, their product development activities and strategies

Executive Summary

Market Dynamics

Drug Therapeutics and Self-Administration

Transdermal Drug Delivery Demand Factors

Competitive Landscape

Factors Limiting Growth

Transdermal Drug Patch Development Factors

The Design Cycle

Design Partnerships

Patch Product Testing

Trials and Submissions

Pharmacokinetics & Dosage Forms

Patch Manufacturing Dynamics

Patch Design & Acceptance Factors

Dosing and Rate Factors

Materials Compatibility

Clinical Trial Process

Biocompatibility

New Generation Drug Patch Products

Patch Products Based on New or Enhanced Drug Patch Technology

Hydrogels

Microprocessor-based

Microstructures

Phase Transition

Single-step Applicator-enabled

Two-Step Delivery

Patch Products Based on New Therapeutic Drug Classes

Metabolic Conditions

Narcotic Pain Management

Neurology

NSAIDs

Peptides

Business and Market Factors

Quality and Reliability

Managed Care and Payor Initiatives

Skin Patch Revenue Models

Regulatory Factors

Clinical Trial Factors

The Impact of Generics

Profiles of Market Participants

To order this report:

Drug Delivery Technology Industry: Transdermal Drug Patches: the Next Generation

Drug Delivery Technology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com